Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

MD, Cappellini; J, Porter; A, El-Beshlawy; CK, Li; JF, Seymour; M, Elalfy; N, Gattermann; S, Giraudier; JW, Lee; LL, Chan; KH, Lin; KH, Lin; C, Rose; A, Taher; SL, Thein; V, Viprakasit; D, Habr; G, Domokos; B, Roubert; A, Kattamis

doi:10.3324/haematol.2009.014696

Public

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

Shared by NobleBlocks on Nov 30, 2009 • 12:00 AM UTC

Authors:

Cappellini MD

Porter J

El-Beshlawy A

Abstract

Unlabelled Background Following a clinical evaluation of deferasirox (Exjade) it was concluded that, in addition to baseline body iron burden, ongoing transfusional iron intake should be considered when selecting doses. The 1-year EPIC study, the largest ever investigation conducted for an iron chel...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!